Childhood Immunisations

CHILDHOOD IMMUNISATION PROGRAMME

At 2 months

Polio, Diptheria, Tetanus, Whooping Cough (pertussis), Influenzae Type b (Hib) (The 5-in-1 vaccine)

Pneumococcal Disease

Meningococcal B (Men B) From September 2015

Patients receive appointment by Phone or Post (Mothers 8wk Post-natal will be carried out at the same time)

 ____________________

At 3 months

Polio, Diptheria, Tetanus, Whooping Cough (pertussis), Influenzae Type b (Hib) (The 5-in-1 vaccine)

Meningococcal group C

Patients advised to book one month after 1st vaccination

 ____________________

At 4 months

Polio, Diptheria, Tetanus, Whooping Cough (pertussis), Influenzae Type b (Hib) (The 5-in-1 vaccine)

Meningococcal B (Men B) From September 2015

Meningococcal group C

Pneumococcal Disease

Patients advised to book one month after 2nd vaccination

 ____________________

­­At 12 to 13 months – within a month of the first birthday

Influenzae Type b (Hib), Meningococcal group C

Pneumococcal Disease

Measles, Mumps and Rubella

Meningococcal B (Men B) Booster From September 2015

Patients receive appointment by Phone or Post 

____________________

At 3yrs4mths to 5yrs (Pre-School)

Polio, Diphtheria, Tetanus, Whooping Cough (Pertussis) (The 4-in-1 Pre-School Booster)

Measles, Mumps and Rubella

Patients receive appointment by Phone or Post 

 ____________________

Girls aged 12 to 13yrs

HPV

Patients receive vaccination at school, this can be administered at the surgery if patient is unable to attend the school appointment

 ____________________

At 13yrs to 18yrs

Polio, Tetanus and Diphtheria

Patients to Book this appointment with the Surgery

 

  ­­­ GAPS BETWEEN VACCINATIONS CANNOT BE SHORTENED BUT CAN BE EXTENDED

 

Vaccine Information

 5-in-1 vaccine:       

The brand name of the 5-in-1 vaccine usually given in the UK is Pediacel.  The 5-in-1 vaccine is a single injection to boost your baby's protection against five different childhood diseases, diphtheria, tetanus, whooping cough (pertussis), polio, and Hib (Haemophilus influenzae type b).

The 5-in-1 vaccine works well and is very safe. It's inactivated which means it doesn't contain any live organisms so there is no risk of your baby catching the diseases against which it protects.  The vaccine also has few side effects although it's common for babies to be a little irritable afterwards and have minor and short-lived redness and swelling at the injection site.

Pneumococcal or pneumo jab (PCV):

The pneumococcal vaccine (or 'pneumo jab' or pneumonia vaccine as it's also known) protects against pneumococcal infections. Pneumococcal infections are caused by the bacterium Streptococcus pneumoniae and can lead to pneumonia, septicaemia (a kind of blood poisoning) and meningitis.

Pneumococcal infections, at their worst, can cause permanent severe brain damage, or even kill. They tend to be most serious in children, older people and people with certain long-term health conditions.  That's why these groups are offered a pneumococcal vaccination on the NHS. It's a simple and safe vaccine that can prevent pneumococcal infections.

Like most vaccines, the pneumococcal vaccine can sometimes cause mild side effects, including:

  • a mild fever
  • redness at the site of the injection
  • hardness or swelling at the site of the injection

There are no serious side effects listed for the childhood vaccine apart from an extremely small risk of serious allergic reaction.

MMR Vaccine

MMR is a safe and effective combined vaccine that protects against three separate illnesses – measles, mumps and rubella (german measles) – in a single injection. The full course of MMR vaccination requires two doses.  Measles, mumps and rubella are common, highly infectious conditions that can have serious, potentially fatal, complications, including meningitis, swelling of the brain (encephalitis), and deafness.  They can also lead to complications in pregnancy that affect the unborn baby and can lead to miscarriage.

Since the MMR vaccine was introduced in 1988, it's rare for children in the UK to develop these serious conditions. However, outbreaks happen and cases of measles in particular have been rising in recent years, so it's important to make sure your children and yourself are up-to-date with MMR vaccination.

Meningococcal B (Men B)

A new vaccine to prevent meningitis will be offered to babies as part of the routine NHS Childhood Vaccination Programme from September 2015.  The Men B vaccine will protect your baby against infection by meningococcal group B bacteria, which can cause meningitis and septicaemia (blood poisoning), which are serious and potentially fatal illnesses.  Meningitis and septicaemia caused by meningococcal group B bacteria can affect people of any age, but is most common in babies and young children.

The new programme makes England the first country in the world to offer a national, routine and publicly funded Men B vaccination programme.  Those babies eligible will be contacted so that we may arrange a suitable appointment for vaccination.

Like all vaccines, the Men B vaccine can cause side effects, but studies suggest they are generally mild and don't last long.  Almost 8,000 people, including more than 5,000 babies and toddlers, have had the new Men B vaccine during clinical trials to test its safety.  Since the vaccine was licensed, almost a million doses have been given, with no safety concerns identified.  Babies given the Men B vaccine alongside their other routine vaccinations at two and four months are likely to develop fever within the first 24 hours after vaccination.

Giving your baby liquid paracetamol will reduce the risk of fever after vaccination. Your nurse will give you more information about paracetamol at your vaccination appointment.  Other common side effects include irritability and redness and tenderness at the injection site. The liquid paracetamol will also help with these symptoms.

Meningococcal C (Men C)

The Men C vaccine protects against infection by meningococcal group C bacteria, which can cause two very serious illnesses, meningitis and septicaemia.  Meningococcal disease can affect all age groups, but the rates of disease are highest in children under five years of age, with the peak in babies under one year of age. There's a second peak in cases in young people aged between 15 and 19. The disease tends to strike in winter.

The Men C vaccine has an excellent safety record. The most common reactions tend to be minor and very temporary. They include swelling, redness and pain around the injection site, fever, and vomiting.  The Men C vaccine works very well and has slashed the levels of Men C disease. Since the Men C vaccine was introduced into the NHS's national childhood vaccination programme in 1999, the disease has been virtually eliminated in the UK. Nowadays, there are just a handful of Men C cases each year, mainly in older, unvaccinated adults.

4-in-1 pre-school booster

Also known as the DTaP/IPV (or dTaP/IPV) vaccine or simply the 'pre-school booster', the 4-in-1 pre-school booster vaccine is given to three-year-old children to boost their protection against:

Children are routinely vaccinated against these illnesses as babies. This booster increases their immunity even further.

In clinical trials, more than 99% of children who had been given the pre-school booster developed protection against tetanus, diphtheria, whooping cough and polio. The vaccines protect children from these infections until they receive their teenage booster between the ages of 13 and 18.

HPV vaccine (girls only)

The human papilloma virus (HPV) is the name given to a family of viruses.  Different types of HPV are classed as either high risk or low risk, depending on the conditions they can cause. For instance, some types of HPV can cause warts or verrucas. Other types are associated with cervical cancer.

All girls aged 12 to 13 are offered HPV (human papilloma virus) vaccination as part of the NHS childhood vaccination programme. The vaccine protects against cervical cancer. It's usually given to girls in year eight at schools in England.  According to Cancer Research UK, cervical cancer is the second most common cancer in women under the age of 35. In the UK, 2,900 women a year are diagnosed with cervical cancer, that's around eight women every day.  Around 970 women died from cervical cancer in 2011 in the UK. It's estimated that about 400 lives could be saved every year in the UK as a result of vaccinating girls before they are infected with HPV.

The HPV vaccine is delivered largely through secondary schools, and consists of two injections into the upper arm spaced at least six, and not more than 24 months apart (girls who began vaccination before September 2014 receive three injections).

Research has indicated that the HPV vaccine protects against cervical cancer for at least 20 years.